Breaking
Friday, June 19, 2026

Drug Approvals

🇺🇸 FDA Page 5

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 49–60 of 665 articles

High impact AnalysisJun 7, 2026

Lenacapavir PrEP shows high HIV-prevention efficacy in Gilead’s Phase 3 trials

oncology · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

Vertex launches Journavx after FDA approval for acute pain

FDA · oncology · 9 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

AstraZeneca and Daiichi Sankyo datopotamab deruxtecan hits lung cancer endpoint

oncology · 8 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda adjuvant NSCLC use in early-stage lung cancer

FDA · oncology · 7 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

FDA approves Keytruda adjuvant NSCLC use: what Merck investors should watch

FDA · oncology · 7 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk CagriSema Phase 3 Obesity Results Signal Key Catalyst

EMA · oncology · 5 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

Gene Therapy FDA Approval for Rare Disease: Updated List and Analysis

FDA · rare disease · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Facet Life Sciences Appoints Frank Closurdo as VP, Commercial Services

5 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 6, 2026

Amneal Romidepsin FDA Approval: B2B Analysis for BD Teams and Investors

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Summit Pipeline Approvals and Competitive Outlook: 2023-2024 Update

6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Listeria Outbreaks 2026: FDA and CDC Soft Cheese Recall Analysis for Pharma

FDA · oncology · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis

FDA · oncology · 6 min

Dr. Sarah Mitchell